Navin Fluorine Q1 Results: PAT Doubles, INR 90 cr Capex Approved

Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionExceptional ItemResults View source PDF Explain this filing

NAVINFLUOR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+13.1%Reaction day

₹7620.00

prior close

₹7950.00

announcement price

After-mkt

timing

Nifty Smallcap 250market+0.2%+12.9% vs market

Specialty Chemicals peers, median of 96sector+0.1%+13.0% vs sector

On the reaction day the stock moved 12.9 pts more than Nifty Smallcap 250 and 13.0 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.8

10m

+1.9

15m

+2.2

30m

+1.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+13.1+0.2+12.9+0.1+13.0

Next day

+8.0+0.2+7.8+0.1+8.0

+7.7+0.1+7.6+0.2+7.6

+7.0+0.3+6.7+0.4+6.6

+9.7+0.1+9.7+0.7+9.1

+8.9+0.2+8.6+0.3+8.6

+6.9-0.1+7.0-0.9+7.9

15d

+12.3+0.6+11.7+0.7+11.6

+12.6+0.9+11.7+1.7+10.9

+12.5-2.3+14.8+2.4+10.1

—————

UpDownMarket · Nifty Smallcap 250Sector · Specialty Chemicals peers, median of 96Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Consolidated Q1 FY27 revenue grew 44% YoY to INR 1,045 cr; PAT more than doubled to INR 243 cr (EPS INR 47.45). Standalone revenue rose 28% to INR 695 cr with PAT up 69% at INR 191 cr. Board approved INR 90 cr capex at Surat unit to scale Advanced Materials from lab to commercial level by Q2 FY28, funded via internal accruals.

Likely market impact

Strong earnings beat signals robust demand and margin gains; capex outlay reflects confidence in Advanced Materials growth runway.